Anti-West Nile virus activity of in vitro expanded human primary natural killer cells - Test2 - elhamkhani - TriplyDB

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

http://www.wikidata.org/entity/Q27490927

about

Role of natural killer and Gamma-delta T cells in West Nile virus infection Systems analysis of West Nile virus infection Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection Allogenic natural killer cell immunotherapy of sizeable ovarian cancer: A case report Molecular Mechanisms of Interaction Between Human Immune Cells and Far Eastern Tick-Borne Encephalitis Virus Strains Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility.Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain.A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes West Nile virus infection and immunity.Role of Immune Aging in Susceptibility to West Nile Virus.Age-related alterations in immune responses to West Nile virus infection.Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer.Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC).Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection Direct Antiviral Mechanisms of Interferon-Gamma

P2860

Q27007830-C40CA081-2C77-4622-839F-E56C24408D8A Q27012977-1EF688DF-FF36-40FF-8257-BD9A356408A4 Q27304916-5C7CEF56-91C1-4A54-B291-AC86B8E5D7EF Q29365826-12DDEAEA-B23C-44B7-9342-3A4960985040 Q33748308-DA8CB70B-E19D-42BD-96E0-F47B954B66CC Q35801621-25018A5C-335C-4907-9420-0F05D0541DEB Q35990726-37CFC480-96BF-41E3-AFE0-060B6AF596BA Q36081725-234465AC-B799-4752-B737-4000DF5BEC9A Q36594860-AE7D896D-3178-475A-81B6-126A608616AF Q38074266-2A746963-3D7B-447D-B2C7-98EEE9AAECBC Q38836544-964C6922-C5D9-44FE-947E-6D081710D57C Q38950405-A804CEA6-E87B-4FEA-8C10-E295A74E93C2 Q40040718-D68543CB-AF4A-4530-BC3E-DE1C41A17F41 Q47105585-CCACB9F0-B2A5-479B-A5F3-FC94186A34CB Q47135740-7856BCFF-6710-43C6-A2C5-E80A3BC19F4B Q50145104-758A2C6B-3DD6-44FF-8B2C-68DC2B49A690 Q52770412-AF89B8CF-ED48-4A36-A09E-82675BCD37D7 Q52779233-C020C88D-A2F2-45D2-BE8B-2C5687955115 Q55005404-F819512F-9FF6-4BB5-8E74-7D733532EFA1 Q57491432-85711F75-CD8F-436A-A0F0-9F57959BC27F Q58543753-A68442A7-4586-4EFE-8E52-4628D99B607B

P2860

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

http://www.wikidata.org/entity/Q27490927

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@ast

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@en

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@nl

type

label

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@ast

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@en

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@nl

prefLabel

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@ast

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@en

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@nl

P1433

Q27490927-F4F8FD5A-CA9E-4257-BAD4-493694D3B55B

P1476

Q27490927-F2CC3548-D0D2-46ED-8A0E-9BE19140C494

P2093

Q27490927-09FE2A00-07F6-4D4D-9B63-12878F43E8AE

Q27490927-206FEA08-A8F1-4E00-B188-B484D72C9BFF

Q27490927-2ADA74FE-F965-4E3A-A639-35CE796F34A3

Q27490927-5D8F579E-79ED-45C8-B142-12FFB467181D

Q27490927-777398CB-DA74-4661-B251-5F4DA712A805

Q27490927-9499327B-A534-49E3-9CA5-55668265913B

Q27490927-9D48E9B1-D084-467C-B3E0-5A24B970929E

Q27490927-AEE02DFA-5B9E-44F2-9268-F67B79FD1A81

Q27490927-B5EED25B-244F-4EA8-A7A4-EA890BF9B573

P2860

Q27490927-04B58E73-45D2-4A1C-83A4-98CE27059275

Q27490927-07F34D4C-2854-4666-9A05-75425E59DC34

Q27490927-18564C74-AC58-49AD-BBFF-E70B0ED45EF5

Q27490927-331B7415-E17A-4D32-A589-697491101A2E

Q27490927-48F45297-77B6-4899-B252-30199A2C2F48

Q27490927-54669116-2843-4CD4-9CDE-11185091387B

Q27490927-5D379409-7A45-4CD3-9282-0E29290CFC82

Q27490927-7AD93EA1-CF24-42E0-9025-A7626E09FC37

Q27490927-9235718E-7AB4-4DB7-B770-43416019D890

Q27490927-9985C991-F00B-4C4E-9E0B-A31FCDC803B2

P2888

Q27490927-DE986971-B366-43C7-9848-4FA27B036C91

P304

Q27490927-38FB6988-A97B-41C1-934E-1D8342521CD0

P31

Q27490927-F206F983-D85C-4284-8003-8619F39C24A6

P356

Q27490927-C95FD030-87CA-4833-ABEA-2987D068805E

P433

Q27490927-866A2DB3-FAE0-41E0-ABBD-0AC85A744572

P478

Q27490927-398B32ED-13C0-4872-8B16-8E1D7006987C

P50

Q27490927-6433F2C6-CB3F-41D3-9105-D5B5D242B671

P577

Q27490927-5C688811-B15B-4B71-96B4-CC1399DC17C2

P5875

Q27490927-840D6733-79A9-4E5B-B792-8406F07FB9B7

P6179

Q27490927-97B3D3B6-4B65-49F7-998E-1C28279AC0EE

P698

Q27490927-8241B0D1-A2D6-42BF-B744-8C1FBEDE7AC3

P921

Q27490927-9931AF64-8461-42C3-A6F1-258754470F89

P932

Q27490927-7545D952-B30E-43A0-8236-D77BF8CCC8D9

P356

P1433

P1476

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

@en

P2093

Andrew Dayton

http://www.w3.org/2001/XMLSchema#string

Andriyan Grinev

http://www.w3.org/2001/XMLSchema#string

Caren Chancey

http://www.w3.org/2001/XMLSchema#string

Howard Mostowski

http://www.w3.org/2001/XMLSchema#string

Mingjie Zhang

http://www.w3.org/2001/XMLSchema#string

Qingsheng Huang

http://www.w3.org/2001/XMLSchema#string

Sylvester Daniel

http://www.w3.org/2001/XMLSchema#string

Ying F Lei

http://www.w3.org/2001/XMLSchema#string

Yong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection

CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.

Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells.

Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.

Natural killer cell-based immunotherapeutic strategies.

Tumor and viral recognition by natural killer cells receptors.

P2888

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2172-11-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41101538

http://www.w3.org/2001/XMLSchema#string

P6179

1046201813

http://www.w3.org/2001/XMLSchema#string

P698

20089143

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

2822749

http://www.w3.org/2001/XMLSchema#string